Drug name - Signifor Lar Kit

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7473761 RECORDATI RARE Somatostatin analogues
Dec, 2026

(4 years from now)

CN1267451C RECORDATI RARE Somatostatin Analogues
Jul, 2021

(1 year, 2 months ago)

CN1446229A RECORDATI RARE Somatostatin Analogues
Jul, 2021

(1 year, 2 months ago)

IN200300143P4 RECORDATI RARE Somatostatin Peptidomimetics
Jul, 2021

(1 year, 2 months ago)

IN204073B RECORDATI RARE Somatostatin Peptidomimetics
Jul, 2021

(1 year, 2 months ago)

EP1307486B1 RECORDATI RARE Somatostatin Analogues
Jul, 2026

(3 years from now)

EP1307486A2 RECORDATI RARE Somatostatin Analogues
Jul, 2026

(3 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8822637 RECORDATI RARE Somatostatin analogues Aug, 2023

(10 months from now)

US7759308 RECORDATI RARE Microparticles comprising somatostatin analogues Oct, 2026

(4 years from now)

US9351923 RECORDATI RARE Extended-release composition comprising a somatostatin derivative in microparticles May, 2028

(5 years from now)

Drugs and Companies using PASIREOTIDE PAMOATE ingredient

Treatment: Method of treating acromegaly

Dosage: FOR SUSPENSION;INTRAMUSCULAR

More Information on Dosage
Strength Dosage Availability
EQ 10MG BASE/VIAL FOR SUSPENSION;INTRAMUSCULAR Prescription
EQ 20MG BASE/VIAL FOR SUSPENSION;INTRAMUSCULAR Prescription
EQ 30MG BASE/VIAL FOR SUSPENSION;INTRAMUSCULAR Prescription
EQ 40MG BASE/VIAL FOR SUSPENSION;INTRAMUSCULAR Prescription
EQ 60MG BASE/VIAL FOR SUSPENSION;INTRAMUSCULAR Prescription

availability in other generic markets.

Click on the highlighted region to filter.